Synopsis
Synopsis
0
USDMF
0
KDMF
0
NDC API
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Akineton
2. Alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
3. Biperiden
4. Biperiden, 1r-(1 Alpha,2 Alpha(r*),4 Alpha)-isomer
5. Biperiden, 1s-(1 Alpha,2 Alpha(r*),4 Alpha)-isomer
6. Biperidene
7. Hydrochloride, Biperiden
1. 1235-82-1
2. Akineton
3. Akinophyl
4. Biperiden Hcl
5. Biperiden (hydrochloride)
6. Akineton Hydrochloride
7. Biperidine Hydrochloride
8. Tasmolin
9. Kl 373 (hydrochloride)
10. Biperidene Hydrochloride
11. Nsc-84989
12. Nsc-170950
13. K35n76cuhf
14. 1-bicycloheptenyl-1-phenyl-3-piperidinopropanol-1 Hydrochloride
15. Tasmolin (tn)
16. 1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol;hydrochloride
17. Dsstox_cid_27832
18. Dsstox_rid_82595
19. Dsstox_gsid_47856
20. 1-piperidinepropanol, Alpha-bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-, Hydrochloride (1:1)
21. Akineton, Hydrochloride
22. Chebi:59171
23. Smr001456154
24. Wln: L55 A Cutj Fxqr&2- At6ntj &gh
25. Ncgc00182965-01
26. Einecs 214-976-2
27. Nsc 84989
28. Unii-k35n76cuhf
29. Nsc 170950
30. Sr-05000001649
31. .alpha.-5-norbornen-2-yl-.alpha.-phenyl-piperidinepropanol Hydrochloride
32. .alpha.-[bicyclo[2.2.1]hept-5-en-2-yl]-.alpha.-phenyl-1-piperidinepropanol Hydrochloride
33. Prestwick_839
34. Biperiden Hydrochloride [usp:ban:jan]
35. Biperideni Hydrochloridum
36. 1-piperidinepropanol, .alpha.-bicyclo(2.2.1)hept-5-en-2-yl-.alpha.-phenyl-, Hydrochloride
37. Alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinepropanol Hydrochloride
38. Cas-1235-82-1
39. 1-piperidinepropanol, Alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-, Hydrochloride
40. Alpha-(bicyclo(2.2.1)hept-5-en-2-yl)-alpha-phenyl-1-piperidinepropanol Hydrochloride
41. Piperidinepropanol, Alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-, Hydrochloride
42. Schembl40776
43. Mls003915621
44. Mls006011163
45. Chembl1201035
46. Dtxsid2047856
47. Hms1569f05
48. Nsc84989
49. Biperiden Hydrochloride [mi]
50. Tox21_112785
51. Tox21_113064
52. Tox21_500217
53. Biperiden Hydrochloride (jp17/usp)
54. Biperiden Hydrochloride [jan]
55. Nsc170950
56. 1-piperidinepropanol, Alpha-5-norbornen-2-yl-alpha-phenyl-, Hydrochloride
57. Akos024457314
58. Tox21_112785_1
59. Bcp9000415
60. Biperiden Hydrochloride [mart.]
61. Biperiden Hydrochloride [vandf]
62. Ccg-221521
63. Cs-0442
64. Lp00217
65. 1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-(1-piperidinyl)propan-1-ol Hydrochloride
66. Biperiden Hydrochloride [who-dd]
67. Biperiden Hydrochloride [who-ip]
68. Ncgc00182965-05
69. Ncgc00260902-01
70. Hy-13204
71. Biperiden Hydrochloride [orange Book]
72. Sw196970-2
73. Biperiden Hydrochloride [ep Monograph]
74. Biperiden Hydrochloride [usp Impurity]
75. D02246
76. Biperiden Hydrochloride, >=98% (hplc), Powder
77. Biperideni Hydrochloridum [who-ip Latin]
78. J-004957
79. Sr-05000001649-3
80. Q27126508
81. 1-bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-ylpropan-1-ol Hcl
82. .alpha.-5-norbornen-2-yl-.alpha.-phenyl-1-piperidinepropanol Hydrochloride
83. 1-(bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-olhydrochloride
Molecular Weight | 347.9 g/mol |
---|---|
Molecular Formula | C21H30ClNO |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 5 |
Exact Mass | 347.2015923 g/mol |
Monoisotopic Mass | 347.2015923 g/mol |
Topological Polar Surface Area | 23.5 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 422 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 4 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?